期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (6)
Background Previous research demonstrated that short-term treatment of dilated cardiomyopathy with thyroid hormones exerted beneficial hemodynamic eff......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (2)
Acute hypertension, which may damage blood vessels, causes irreversible organ damage to the vasculature, central nervous system, kidney, and heart. Cl......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (6)
Mechanical heart valves (MHVs) replacement is recommended for younger patients with valvular heart disease because of the durability of the mechanical......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (6)
Purpose It is unknown if acute coronary syndrome (ACS) patients presenting with advanced Killip class (III/IV) would benefit from early statin therapy......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (3)
Background Ivabradine improves cardiac function and clinical outcomes in chronic heart failure (HF) by reducing heart rate (HR), but there is a lack o......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (6)
Background The role of aspirin in cardiovascular primary prevention remains controversial. Moreover, evidence for the potential benefits of aspirin in......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (5)
Objective This study aimed to investigate the effectiveness and safety of idarucizumab for periprocedural cardiac tamponade after catheter ablation of......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (2)
Background Myopathy is the most widely reported statin-associated adverse event. Several studies have linked vitamin D deficiency with statin-related ......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (1)
Background The relative efficacy of different sodium-glucose transporter 2 inhibitors (SGLT2i) on cardiorenal outcomes is unclear. Methods We included......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022; 22 (6)
Among all of the new antidiabetic drugs, an increasing number of studies have evaluated the relationship between the sodium-glucose cotransporter 2 in......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, ; ()
Background Information is lacking on long-term management of patients with acute coronary syndrome (ACS) and chronic kidney disease (CKD) (estimated g......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020; 20 (5)
Background The addition of alirocumab (a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 [PCSK9]) to background stati......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020; 20 (1)
Objectives Concerns have arisen recently over the relationship between body mass index (BMI) and outcomes in atrial fibrillation (AF) patients with di......
期刊： AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020; 20 (2)
Background The amelioration of myocardial reperfusion in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary inte......
